<?xml version="1.0" encoding="UTF-8" standalone="no"?>
<ibecs-document>
<record>
<header>
<identifier>ibc-112511</identifier>
<setSpec>1699-258X</setSpec>
</header>
<metadata xmlns="http://example.org/myapp/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:dcterms="http://purl.org/dc/terms/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://example.org/myapp/schema.xsd">
<dc:title xml:lang="en">Tocilizumab in a patient with tophaceous gout resistant to treatment</dc:title>
<dc:description xml:lang="en">Gout is a disease characterized by acute episodes of pain, which occurs as the result of monosodic urate crystal deposit in the joint and periarticular tissue. In some cases, gout behaves as a severe inflammatory arthopathy that is difficult to manage, generating structural joint damage and functional impairment. We report the case of a 44 years old man with gouty arthritis for 12 years, not responding to NSAIDs, alopurinol, colchicine or corticosteroids. Tocilizumab was started with favorable clinical and laboratory results after treatment(AU)</dc:description>
<dc:creator>Gutiérrez, Juan M</dc:creator>
<dc:creator>Díaz, María C</dc:creator>
<dc:creator>Pinto, Jessica L</dc:creator>
<dc:creator>Mora, Gloria E</dc:creator>
<dc:creator>Fernández-Avila, Daniel G</dc:creator>
<dc:language>es</dc:language>
<dc:description xml:lang="es">La gota es una enfermedad que se caracteriza por episodios agudos de dolor como consecuencia del depósito de cristales de urato monosódico en las articulaciones y en el tejido periarticular. En algunos casos, la gota se comporta como una artropatía inflamatoria severa de difícil manejo, generándose daño estructural articular y alteración funcional secundaria. Presentamos el caso de un hombre de 44 años con artritis gotosa tofácea severa de 12 años de evolución, sin respuesta al manejo con AINE, alopurinol, colchicina y corticoides, a quien se inició tratamiento con tocilizumab, con favorable respuesta clínica y paraclínica(AU)</dc:description>
<dc:source>Reumatol. clín. (Barc.);9(3): 178-180, mayo 2013. tab</dc:source>
<dc:identifier>ibc-112511</dc:identifier>
<dc:title xml:lang="es">Tocilizumab en paciente con gota tofácea severa refractaria al tratamiento</dc:title>
<dc:subject>^d23659^s22057</dc:subject>
<dc:subject>^d28079^s22073</dc:subject>
<dc:subject>^d23659^s22012</dc:subject>
<dc:subject>^d23659^s22016</dc:subject>
<dc:subject>^d21012</dc:subject>
<dc:subject>^d21034</dc:subject>
<dc:subject>^d23659^s22032</dc:subject>
<dc:subject>^d21044</dc:subject>
<dc:subject>^d1184^s22012</dc:subject>
<dc:subject>^d331</dc:subject>
<dc:subject>^d6223^s22016</dc:subject>
<dc:subject>^d6223^s22057</dc:subject>
<dc:subject>^d6223^s22012</dc:subject>
<dc:subject>^d6223^s22067</dc:subject>
<dc:subject>^d6223^s22032</dc:subject>
<dc:subject>^d25575^s22045</dc:subject>
<dc:type>article</dc:type>
<dc:date>201305</dc:date>
</metadata>
</record>
</ibecs-document>
